[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:hepatitis-b-infection":3},{"name":4,"total":5,"recruiting":6,"trials":7},"Hepatitis B Infection",39,30,[8,16,23,29,36,42,48,54,60,66,72,78,84,90,96,102,108,114,120,126,132,138,144,150,156,162,168,174,180,186,192,199,205,211,217,222,230,237,243],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07308886","Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)",[12],"Phase 2","RECRUITING","2026-08-26T02:17:16.980188Z","2026-07-05T05:32:16.676145Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07249840","Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis",[20],"Phase 1","2026-08-26T02:17:04.346841Z","2026-07-05T05:32:16.671391Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07619339","A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer",[20],"2026-08-26T02:15:18.897219Z","2026-06-04T01:30:07.903453Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT07479979","Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and\u002For Refractory Multiple Myeloma",[33],"Phase 1\u002FPhase 2","2026-08-26T02:18:35.425468Z","2026-05-29T15:36:40.195056Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT07433673","Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)",[12],"2026-08-26T02:19:08.084946Z","2026-05-05T02:43:29.707381Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT05366829","Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma",[12],"2026-08-26T02:16:12.203827Z","2026-05-05T02:43:29.682232Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT05665738","Two-fraction HDR Monotherapy for Localized Prostate Cancer",[],"2026-08-26T02:15:58.452248Z","2026-05-05T02:43:29.533094Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT06223568","Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer",[12],"2026-08-03T03:13:22.003666Z","2026-05-05T02:43:29.471790Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT07024641","A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection",[20],"2026-08-26T02:19:19.162260Z","2026-05-05T02:43:29.364387Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT04843852","TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B",[20],"2026-08-26T02:17:16.126291Z","2026-05-05T02:43:29.327590Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT05655949","Y-90 With Durvalumab\u002FGem\u002FCis in Intrahepatic Cholangio",[12],"2026-08-26T02:15:36.077529Z","2026-05-05T02:43:29.327321Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT05797805","A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma",[33],"2026-08-26T02:17:11.311767Z","2026-05-05T02:43:29.284306Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT06963710","A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)",[12],"2026-08-03T01:56:45.025842Z","2026-05-05T02:43:28.740314Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT04496479","Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes",[12],"2026-08-26T02:17:17.791881Z","2026-05-05T02:43:28.211385Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":100,"content_modified":101},"NCT05967182","A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma",[12],"2026-08-26T02:18:24.494016Z","2026-05-05T02:43:28.207276Z",{"nct_id":103,"title":104,"phases":105,"status":13,"updated_at":106,"content_modified":107},"NCT06001658","Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers",[12],"2026-08-26T02:15:47.754948Z","2026-05-05T02:43:27.840351Z",{"nct_id":109,"title":110,"phases":111,"status":13,"updated_at":112,"content_modified":113},"NCT06052618","Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)",[12],"2026-08-26T02:19:05.360997Z","2026-05-05T02:43:27.493473Z",{"nct_id":115,"title":116,"phases":117,"status":13,"updated_at":118,"content_modified":119},"NCT05856890","HepB mAb19 in Individuals With Chronic Hepatitis B Infection",[20],"2026-08-26T02:16:31.714843Z","2026-05-05T02:43:27.491318Z",{"nct_id":121,"title":122,"phases":123,"status":13,"updated_at":124,"content_modified":125},"NCT05096715","Atezolizumab+Bevacizumab+SBRT in Unresectable HCC",[20],"2026-08-26T02:16:41.943926Z","2026-05-05T02:43:27.321203Z",{"nct_id":127,"title":128,"phases":129,"status":13,"updated_at":130,"content_modified":131},"NCT06569147","Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis",[33],"2026-08-26T02:18:17.950264Z","2026-05-05T02:43:27.288200Z",{"nct_id":133,"title":134,"phases":135,"status":13,"updated_at":136,"content_modified":137},"NCT05168163","Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer",[12],"2026-08-26T02:19:14.560989Z","2026-05-05T02:43:27.258385Z",{"nct_id":139,"title":140,"phases":141,"status":13,"updated_at":142,"content_modified":143},"NCT05832229","Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States",[12],"2026-08-26T02:16:28.221034Z","2026-05-05T02:43:27.134034Z",{"nct_id":145,"title":146,"phases":147,"status":13,"updated_at":148,"content_modified":149},"NCT04941274","Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma",[33],"2026-08-26T02:16:54.044282Z","2026-05-05T02:43:26.742813Z",{"nct_id":151,"title":152,"phases":153,"status":13,"updated_at":154,"content_modified":155},"NCT06294548","A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC",[33],"2026-08-26T02:16:10.529598Z","2026-05-05T02:35:31.896999Z",{"nct_id":157,"title":158,"phases":159,"status":13,"updated_at":160,"content_modified":161},"NCT06213311","A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma",[12],"2026-08-26T02:17:01.714035Z","2026-04-29T02:57:57.157278Z",{"nct_id":163,"title":164,"phases":165,"status":13,"updated_at":166,"content_modified":167},"NCT04524871","A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)",[33],"2026-08-26T02:18:51.833592Z","2026-04-29T02:57:57.128598Z",{"nct_id":169,"title":170,"phases":171,"status":13,"updated_at":172,"content_modified":173},"NCT07097363","Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma",[12],"2026-08-26T02:19:30.857183Z","2026-05-05T02:43:27.261789Z",{"nct_id":175,"title":176,"phases":177,"status":13,"updated_at":178,"content_modified":179},"NCT03125642","Auto Stem Cell Transplant for Lymphoma Patients",[12],"2026-08-26T02:16:13.426928Z","2026-05-05T02:43:26.753431Z",{"nct_id":181,"title":182,"phases":183,"status":13,"updated_at":184,"content_modified":185},"NCT07654283","Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions",[12],"2026-08-26T02:16:39.977107Z","2026-06-17T19:21:16.688868Z",{"nct_id":187,"title":188,"phases":189,"status":13,"updated_at":190,"content_modified":191},"NCT06154278","Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B",[12],"2026-08-26T02:19:13.549512Z","2026-05-05T02:43:27.958288Z",{"nct_id":193,"title":194,"phases":195,"status":196,"updated_at":197,"content_modified":198},"NCT07672483","IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid Tumors",[20],"NOT_YET_RECRUITING","2026-08-26T02:17:02.694423Z","2026-07-05T03:45:20.432490Z",{"nct_id":200,"title":201,"phases":202,"status":196,"updated_at":203,"content_modified":204},"NCT07557056","Nemtabrutinib and Venetoclax for the Treatment of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma",[12],"2026-08-26T02:18:43.501109Z","2026-05-13T02:55:06.723790Z",{"nct_id":206,"title":207,"phases":208,"status":196,"updated_at":209,"content_modified":210},"NCT07667400","Docetaxel and SX-682 in Recurrent\u002FMetastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer",[33],"2026-08-26T02:19:15.498463Z","2026-07-05T03:45:20.369129Z",{"nct_id":212,"title":213,"phases":214,"status":196,"updated_at":215,"content_modified":216},"NCT07646821","A Phase 1b\u002F2 Study of Ropeginterferon Alfa-2b Added to Azacitidine in Newly Diagnosed MDS\u002FAML (≥ 10% Blasts) With TP53 Mutations",[33],"2026-08-26T02:16:47.762107Z","2026-06-16T05:54:07.902931Z",{"nct_id":218,"title":219,"phases":220,"status":196,"updated_at":166,"content_modified":221},"NCT06994130","Seravue Validation Study for Hepatocellular Carcinoma (HCC) Diagnosis",[],"2026-05-13T02:55:06.604429Z",{"nct_id":223,"title":224,"phases":225,"status":227,"updated_at":228,"content_modified":229},"NCT06782399","Drug Screening of Cutaneous Lesions of Squamous Cell Carcinoma",[226],"Early Phase 1","ENROLLING_BY_INVITATION","2026-08-26T02:17:07.954622Z","2026-06-16T05:54:07.770961Z",{"nct_id":231,"title":232,"phases":233,"status":234,"updated_at":235,"content_modified":236},"NCT04954859","Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)",[12],"ACTIVE_NOT_RECRUITING","2026-08-03T03:07:45.344605Z","2026-05-05T02:43:29.709291Z",{"nct_id":238,"title":239,"phases":240,"status":234,"updated_at":241,"content_modified":242},"NCT02932150","Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection",[12],"2026-08-03T01:59:18.089574Z","2026-05-05T02:43:27.089722Z",{"nct_id":244,"title":245,"phases":246,"status":234,"updated_at":247,"content_modified":248},"NCT03482102","Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer",[12],"2026-08-03T03:53:05.241597Z","2026-05-05T02:43:26.965263Z"]